Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns

Pediatr Pulmonol. 2019 May;54(5):637-643. doi: 10.1002/ppul.24265. Epub 2019 Jan 27.

Abstract

Objective: To assess oxygen diffusion at 36 weeks' post-menstrual age in preterm infants by means of the non-invasive oxygen saturation/fraction of inspired oxygen ratio (36w-SFR) and to identify factors associated with 36w-SFR - ie, gestational age (GA) and early respiratory disease patterns (ERP).

Methods: Retrospective analysis of prospectively collected data.

Setting: Neonatal Intensive Care Unit.

Patients: 1005 preterm infants born below 32 weeks' GA.

Interventions: 36w-SFR was the mean of SFR values over 24 h on the day infants reached 36 weeks' PMA.

Main outcome measures: 36w-SFR.

Statistics: descriptive statistics, univariate, and multivariate analysis to study associations of 36w-SFR, including GA and ERP.

Results: 36w-SFR was significantly different between infants with and without bronchopulmonary dysplasia (BPD) (371 vs 467, P < 0.001), and according to ERP (LowFIO2 466, pulmonary improvement-PI 460, pulmonary deterioration-PD 405, early persistent pulmonary deterioration-EPPD 344, P < 0.001). Significant differences were found either in BPD and in non-BPD patients according to ERP (P < 0.001). Patients without BPD had significant differences in 36w-SFR according to GA (P < 0.001), while infants with BPD and increasing GA at birth had a non-significant trend for increased 36w-SFR (P = 0.621). Factors associated with 36w-SFR were GA, being small for GA, sepsis, human milk feeding, and ERP.

Conclusions: Preterm infants without BPD had a spectrum of oxygen diffusion impairment that was inversely associated with GA at birth. Infants with different patterns of ERP had significant differences in 36w-SFR.

Keywords: bronchopulmonary dysplasia; early respiratory disease pattern; oxygen saturation/fraction of inspired oxygen ratio; preterm infant.

MeSH terms

  • Bronchopulmonary Dysplasia / metabolism*
  • Bronchopulmonary Dysplasia / physiopathology
  • Bronchopulmonary Dysplasia / therapy
  • Female
  • Gestational Age*
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Infant, Small for Gestational Age
  • Intensive Care Units, Neonatal
  • Lung / metabolism*
  • Lung / physiopathology
  • Lung Diseases / metabolism
  • Lung Diseases / physiopathology
  • Lung Diseases / therapy
  • Male
  • Milk, Human
  • Neonatal Sepsis
  • Oxygen / metabolism*
  • Oxygen Inhalation Therapy
  • Retrospective Studies
  • Severity of Illness Index

Substances

  • Oxygen